Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Istaroxime in Acute Decompensated Heart Failure
NCT02617446Phase 2Completed
- Sponsor
- Windtree Therapeutics, Inc.
- Start
- Dec 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of istaroxime in heart failure (HF), sponsored by Windtree Therapeutics, Inc.. Started Dec 2015; status: completed.
02
Drugs
istaroxime
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02617446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02617446.